For the Inventor, By the Inventor

Enter assignee name

Winston-Salem, NC, United States of America

Targacept, Inc.

Calculating rank

USPTO Granted Patents = 91

% Expired Patents = 56.0

CIPO Patents = 3

EPO Patents = 13

Forward Citations = 777

Loading Chart...

Loading Chart...

78 inventors (with patents filed for the assignee):

Gary Maurice Dull (45 out of 87 patents)

Balwinder Singh Bhatti (33 out of 43 patents)

Craig Harrison Miller (30 out of 37 patents)

4. Anatoly A Mazurov (23 out of 26 patents)

5. Lan Miao (22 out of 24 patents)

6. Jeffrey Daniel Schmitt (22 out of 24 patents)

7. William Scott Caldwell (20 out of 49 patents)

8. Merouane Bencherif (16 out of 33 patents)

9. Julio A Munoz (14 out of 20 patents)

10. Jared Miller Wagner (12 out of 16 patents)

11. Peter Anthony Crooks (11 out of 97 patents)

12. Srishailkumar Basawannappa Hadimani (10 out of 11 patents)

13. Teresa Phillips (9 out of 9 patents)

14. Jozef Klucik (9 out of 10 patents)

15. John Genus (8 out of 8 patents)

Core Competencies:

Nicotinic Antagonists

Cholinergic Receptors

Pharmaceutical Compositions

CNS Disorders

Aryl Substituted Compounds

Salt Forms

Diazabicycloalkanes

Hydroxybenzoate Salts

Combination Therapy

Neuronal Ligands

Pain Relief

Cognitive Deficits

91 patents: Sort by Forward Citations

1. 9532974 - Nicotinic receptor non-competitive antagonists (2017-01-03),

2. 9145396 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine (2015-09-29),

3. 9107915 - Hydroxybenzoate salts of metanicotine compounds (2015-08-18),

4. 8921410 - Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes (2014-12-30),

5. 8901177 - Method of treating bladder disorders (2014-12-02),

6. 8901151 - Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide (2014-12-02),

7. 8859609 - Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes (2014-10-14),

8. 8846715 - (2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide novel salt forms, and methods of use thereof (2014-09-30),

9. 8809397 - Nicotinic receptor non-competitive antagonists (2014-08-19),

10. 8802694 - 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands (2014-08-12),

11. 8778978 - Hydroxybenzoate salts of metanicotine compounds (2014-07-15),

12. 8703802 - Process for the preparation of aryl substituted olefinic amines (2014-04-22),

13. 8633227 - Synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine (2014-01-21),

14. 8633222 - Arylvinylazacycloalkane compounds and methods of preparation and use thereof (2014-01-21),

15. 8604191 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine (2013-12-10),

Company Overview

Targacept, Inc. is a biopharmaceutical company based in Winston-Salem, North Carolina, specializing in the development of innovative therapies targeting cholinergic receptors. The company focuses on nicotinic antagonists and their applications in treating central nervous system disorders. Targacept's research encompasses a range of advanced pharmaceutical compositions, including aryl substituted compounds and various salt forms, aimed at addressing unmet medical needs in neurological health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

91 Patents

#9 in Winston-Salem, NC

#103 in North Carolina

#4,115 in US

#8,458 in the World

Winston-Salem, NC, United States of America

Targacept, Inc.

Forward Citations = 777

78 inventors:

Gary Maurice Dull (45 out of 87 patents)

Balwinder Singh Bhatti (33 out of 43 patents)

Craig Harrison Miller (30 out of 37 patents)

4. Anatoly A Mazurov (23 out of 26 patents)

5. Lan Miao (22 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Targacept, Inc.. Retrieved from https://idiyas.com/company/targacept

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…